Early Versus Delayed Surgery for Infantile Esotropia

Sponsor
The Hospital for Sick Children (Other)
Overall Status
Completed
CT.gov ID
NCT01166503
Collaborator
(none)
71
1
167.8
0.4

Study Details

Study Description

Brief Summary

The goal of this study is to determine whether corrective surgery done earlier than the current standard can better improve the visual and eye movement deficits in children with infantile esotropia (crossed eyes in infancy).

Condition or Disease Intervention/Treatment Phase
  • Procedure: mVEP Testing
  • Procedure: Stereoacuity Testing
  • Procedure: Optokinetic nystagmus testing
  • Procedure: Motion detection testing
  • Procedure: Motion discrimination testing

Detailed Description

While there is a uniform agreement among pediatric ophthalmologists that most infantile esotropia requires surgical correction, the proper timing of surgery is controversial. In North America, the typical age at surgery ranges from 11-18 months. Unfortunately, despite successful surgical realignment of the eyes, the sensory and eye movement deficits often persist. Recently, some pediatric ophthalmologists have advocated earlier surgery. The rationale for early surgery stems from animal and human research showing that early realignment of the eyes within an early critical period allows normal development of the sensory and eye movement systems.

Study Design

Study Type:
Observational
Actual Enrollment :
71 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Early Versus Delayed Surgery for Infantile Esotropia: A Clinical Evaluation of Sensory and Motor Outcomes
Study Start Date :
May 1, 2004
Actual Primary Completion Date :
Apr 2, 2018
Actual Study Completion Date :
Apr 26, 2018

Arms and Interventions

Arm Intervention/Treatment
Early Surgery

This group will be made up of subjects whose parents choose to have them undergo corrective surgery at or before age 11 months.

Procedure: mVEP Testing
Five small sensors are placed on the head which record the brain's response to moving stripes that are displayed on a computer screen. Each eye is tested while the other eye is patched. Each recording trial lasts about 10 seconds, and several trials are done for each eye.

Procedure: Stereoacuity Testing
Subjects will have their 3D perception measured using standard clinical stereo tests (Randot, Lang, Titmus).

Procedure: Optokinetic nystagmus testing
Subjects will be asked to view a screen with vertical stripes moving in both leftward and rightward directions while their eye movements are recorded using a remote video-based eye tracker.

Procedure: Motion detection testing
Subjects will view a computer screen that has two panels of dots on them. The subject will be required to pick which panel has a section of dots that are moving in a specific direction (ie. nasalward/temporalward).

Procedure: Motion discrimination testing
Subjects will view a computer screen that has two panels of randomly moving dots on them. The subject will be required to pick which panel has a section of dots that are moving in a specific direction (ie. nasalward/temporalward).

Standard Surgery

This group will be made up of subjects who present after age 11 months or whose parents choose to have them undergo corrective surgery between 11-18 months.

Procedure: mVEP Testing
Five small sensors are placed on the head which record the brain's response to moving stripes that are displayed on a computer screen. Each eye is tested while the other eye is patched. Each recording trial lasts about 10 seconds, and several trials are done for each eye.

Procedure: Stereoacuity Testing
Subjects will have their 3D perception measured using standard clinical stereo tests (Randot, Lang, Titmus).

Procedure: Optokinetic nystagmus testing
Subjects will be asked to view a screen with vertical stripes moving in both leftward and rightward directions while their eye movements are recorded using a remote video-based eye tracker.

Procedure: Motion detection testing
Subjects will view a computer screen that has two panels of dots on them. The subject will be required to pick which panel has a section of dots that are moving in a specific direction (ie. nasalward/temporalward).

Procedure: Motion discrimination testing
Subjects will view a computer screen that has two panels of randomly moving dots on them. The subject will be required to pick which panel has a section of dots that are moving in a specific direction (ie. nasalward/temporalward).

Outcome Measures

Primary Outcome Measures

  1. Motion visual evoked potential (mVEPs) asymmetry [at age 2 years]

    mVEP measures the perception of nasalward and temporalward motion for each eye at the cortical level. A nasal bias index (NBI) is calculated, which will show whether subjects perceive motion better for one direction over the other.

  2. Stereopsis [at 2 and 5 years of age]

    This measures the level of 3D depth perception.

  3. Optokinetic nystagmus (OKN) asymmetry [at age 5 years]

    OKN is measured in both the nasalward and temporalward directions for each eye. From this a nasal bias index (NBI) is calculated, which will show whether subjects perceive motion better in one direction or the other.

  4. Global Motion Perception [at 2 and 5 years of age]

    Motion perception will be tested using two tasks: motion detection (at age 2 and 5 years) and motion discrimination (at age 5 years).

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Months to 23 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. onset of esotropia after 10 weeks of age;

  2. constant esotropia ≥ 20° (40 prism diopter or PD) at near (1/3 m) on two examinations, separated by 2-4 weeks; and

  3. refractive error ≤ +3.00 diopters (far-sightedness).

Exclusion Criteria:
  1. gestational age < 34 weeks;

  2. birth weight ≤ 1500 g;

  3. ventilator treatment in the newborn period;

  4. history of meningitis or other major medical event;

  5. developmental delay;

  6. incomitant or paralytic strabismus;

  7. manifest nystagmus or head bobbing;

  8. prior eye muscle surgery;

  9. prior treatment of amblyopia or spectacle correction for refractive errors;

  10. presence of structural ocular anomalies.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Hospital for Sick Children Toronto Ontario Canada M5G 1X8

Sponsors and Collaborators

  • The Hospital for Sick Children

Investigators

  • Principal Investigator: Agnes Wong, MD, The Hospital for Sick Children, Toronto Canada

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Agnes Wong, Ophthamologist-In-Chief, The Hospital for Sick Children
ClinicalTrials.gov Identifier:
NCT01166503
Other Study ID Numbers:
  • 1000005134
First Posted:
Jul 21, 2010
Last Update Posted:
Jun 12, 2018
Last Verified:
Jun 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Agnes Wong, Ophthamologist-In-Chief, The Hospital for Sick Children
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 12, 2018